Why is the Nanosonics share price rocketing 10% today?

Investors are pleased with a big improvement in this company's performance.

| More on:
Man pointing at a blue rising share price graph.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Nanosonics Ltd (ASX: NAN) share price is having a very strong start to the week.

In morning trade, the infection control specialist's shares were up as much as 10% to $3.47.

Why is the Nanosonics share price surging 10%?

Investors have been fighting to get hold of the company's shares on Monday after it released a trading update.

According to the release, Nanosonics delivered strong growth in both capital and consumables/service revenue in the second half compared to the first.

This was particularly the case in the key North America market, which is getting investors excited today.

Management notes that this was driven by additional customer offerings to bridge budget constraints, a number of organisational changes in particular sales territory realignments, and a growing pipeline, together with improvements in sales conversion timelines.

Show me the money

Nanosonics revealed that it expects to report total revenue of approximately $170 million in FY 2024, which is an increase of 2.4% year on year.

This comprises first half revenue of $79.6 million and second half revenue of approximately $90.4 million. The latter represents a half on half increase of 14%.

Nanosonics' second half revenue growth was driven by a 20% half on half increase in capital revenue to $26.4 million and an 11% increase in consumables/service revenue to approximately $64 million.

The company also provided an update on its trophon footprint. It advised that a total of 3,850 trophon units were placed during the year, comprising 2,340 new installed base and 1,510 upgrade units.

For the second half, total units placed were 2,130, up 24% when compared with first half. Whereas new installed base units in the second half were 1,240, which is up 13% half on half. Upgrade unit sales were of 890 for the second half, up 44% on the first half.

The majority of this growth came from North America during the half, with total units placed up 28% to 1,850 and new installed base units up 6% to 1,030.

Nanosonics' CEO and President, Michael Kavanagh, was pleased with the performance. Especially given the challenging trading conditions. He said:

Despite a challenging market environment, the growth opportunity for trophon remains significant. With a growing pipeline for both new installed base and upgrades, it was pleasing to see the sales conversion timelines improve in the second half, which resulted in significant growth in H2 over H1 for capital unit sales.

The Nanosonics share price remains down by almost 30% since this time last year.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Nanosonics. The Motley Fool Australia has positions in and has recommended Nanosonics. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Happy, tablet or doctor in a laboratory with research results or positive feedback after medical data analysis. Smile, vaccine or healthcare worker reading or working on futuristic science innovation.
Healthcare Shares

4 ASX healthcare stocks having a cracking run on Friday

These shares are making their shareholders smile on Friday. What's happening?

Read more »

A man holds his head in his hands, despairing at the bad result he's reading on his computer.
Healthcare Shares

Why is this ASX All Ords stock sinking 14% on Friday?

Let's see why investors hitting the sell button today.

Read more »

healthcare worker overseeing group of aged care residents at table
Healthcare Shares

Up 124% in a year, ASX 300 healthcare share lifts off on $35 million acquisition

ASX investors are bidding up the healthcare share amid ongoing growth.

Read more »

Medical or healthcare workers grasp hands in the universal expression of teamwork
Healthcare Shares

NIB shares slip as health insurer responds to ASX, investors

The company reassured investors and the ASX today.

Read more »

Shot of a scientist using a computer while conducting research in a laboratory.
Healthcare Shares

Why is the ResMed share price taking a thumping on Thursday?

Investors seem to be signalling out ResMed for punishment.

Read more »

A woman leans forward with her hand behind her ear, as if trying to hear information.
Healthcare Shares

Why is the Cochlear share price in the red today?

Investors continue to sell the stock.

Read more »

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

ASX 200 healthcare stock surges amid new takeover rumours

Takeover rumours are circling again for this company.

Read more »

A elder man and woman lean over their balcony with a cuppa, indicating share rpice movement for ASX retirement shares
Healthcare Shares

'Next decade is likely to be a golden era' for ASX shares in this sector

This stock is expected to deliver healthy returns according to a fund manager.

Read more »